Falin Joanne Schaefer, DNP

Falin Schaefer practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Falin Schaefer's NPI, 1548883101, was assigned on May 18, 2020. Falin Schaefer holds California license 95024759.

Falin Schaefer's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Falin Schaefer's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Falin Schaefer is also affiliated with Santa Clara Valley Medical Center. The medical group on file is Stanford Health Care. Dmand AI also links Falin Schaefer to 2 more hospitals and 1 medical group, each named with a free account. Falin Schaefer's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Falin Schaefer practices, 4 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Falin Schaefer's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Falin Schaefer is licensed in California.

Dmand AI lists sleep apnea and tobacco use among the conditions Falin Schaefer treats.

CMS data shows 399 Medicare services from Falin Schaefer across 3 procedure codes in 2024, all of them office visits, for 299 Medicare patients. Medicare paid $34,411 for them.

CMS counts 299 Medicare patients who saw Falin Schaefer in 2024. The largest group is 75 to 84, with 138 patients. 75% of them have heart failure, and 75% have high blood pressure. 24% are also on Medicaid. Their average risk score is 2.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Falin Schaefer's median patient age at 80, with 49% women.

In 2024, Falin Schaefer wrote 156 Medicare Part D claims for 74 patients. 76% of them were for generic drugs. CMS names the drug for 89 of them, across 6 drugs with 11 or more claims each, at $35,068 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Falin Schaefer for performance year 2024, reported as part of a group. Falin Schaefer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Falin Schaefer as offering telehealth.

CMS Open Payments shows 4 general payments to Falin Schaefer from 4 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $115.